Milan: Pharmanutra stands out
(Teleborsa) - The Pharmaceutical company specialized in the development of nutraceutical supplements and medical devices stands out as it trades with a +5.24% increase.The analysis of Pharmanutra's share price on a weekly basis highlights its bullish trend line, as it outperforms the benchmark. Thus the share is showing a greater performance than the FTSE Italia Mid Cap.
Pharmanutra's medium-term situation remains bearish. However, looking at the short-term chart it would be fair to dismiss the possibility that the downtrend will continue for long. An upswing is thus expected, with first resistance at 57.27. Support is at the 54.17 level. Further bullish cues would suggest a new target price in the 60.37 region.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 11-12-2024 12:30 PM